NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

Glas M, Bähr O, Felsberg J, Rasch K, Wiewrodt D, Schabet M, Simon M, Urbach H, Steinbach JP, Rieger J, Fimmers R, Bamberg M, Nägele T, Reifenbergerg G, Weller M, Herrlinger U; Neuro-oncology Group of the German Cancer Society.

Ann Neurol. 2011;70: 445 – 453